New combo therapy aims to outperform standard for tough lung cancers
NCT ID NCT06448312
Summary
This study is testing if a new drug called SKB264 works better when combined with the standard immunotherapy drug pembrolizumab for people with advanced non-small cell lung cancer. It's for patients who haven't had any prior treatment for their advanced cancer and whose tumors have a specific marker (PD-L1 positive). The main goal is to see if the combination helps patients live longer without their cancer getting worse compared to using pembrolizumab alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Guangzhou, China
-
Affiliated Tumor Hospital of Xinjiang Medical University
Xinjiang, China
-
Anhui Provincial Chest Hospital
Hefei, China
-
Army Medical Center of PLA (Daping Hospital)
Chongqing, China
-
Beijing Chest Hospital. Capital Medical University
Beijing, China
-
Beijing Institute for Cancer Research
Beijing, China
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
-
Chengdu Fifth People's Hospital
Chengdu, China
-
China Medical University First Affiliated Hospital
Shenyang, China
-
Chongqing University Cancer Hospital
Chongqing, China
-
Dongguan People's Hospital
Dongguan, China
-
Fujian Cancer Hospital
Fuzhou, China
-
Fujian Medical University Union Hospital
Fuzhou, China
-
Gansu Provincial Cancer Hospital
Lanzhou, China
-
Guangxi Medical University Cancer Hospital
Nanning, China
-
Harbin Medical University Cancer Hospital
Harbin, China
-
Hebei University Affiliated Hospital
Baoding, China
-
Hubei Cancer Hospital
Wuhan, China
-
Hunan Cancer Hospital
Changsha, China
-
Jiangsu Province Hospital
Nanjing, China
-
Jiangxi Cancer Hospital
Nanchang, China
-
Jilin Cancer Hospital
Changchun, China
-
Liaoning Cancer Hospital
Shenyang, China
-
Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Mianyang, China
-
People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, China
-
Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences
Jinan, China
-
Shandong Provincial Hospital
Jinan, China
-
Shanghai Chest Hospital
Shanghai, China
-
Shanghai East Hospital, Tongji University
Shanghai, China
-
Shanghai Pulmonary Hospital
Shanghai, China
-
Shanxi Province Cancer Hospital
Taiyuan, China
-
Shengjing Hospital, China Medical University
Shenyang, China
-
Sichuan Provincial People's Hospital
Chengdu, China
-
Sir Run Run Shaw Hospital (SRRSH)
Hangzhou, China
-
Subei People's Hospital of Jiangsu province
Yangzhou, China
-
Sun Yat-sen Memorial Hospital Sun Yat-sen University
Guangzhou, China
-
Sun Yat-sen University Cancer Center
Guangzhou, China
-
The 2nd Affiliated Hospital of Harbin Medical University
Harbin, China
-
The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital，Henan Academy of Innovations in Medical Science
Zhengzhou, China
-
The First Affiliated Hospital Of Xiamen University
Xiamen, China
-
The First Affiliated Hospital of Henan University of Science & Technology
Luoyang, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, China
-
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, China
-
The First Affiliated Hospital of XiAn Jiaotong University
Xi'an, China
-
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
-
The First Hospital of Jilin University
Changchun, China
-
The Second Affiliated Hospital Of Anhui Medical University
Hefei, China
-
The Second Affiliated Hospital Of Zunyi Medical University
Zunyi, China
-
The Second Affiliated Hospital of Dalian Medical University
Dalian, China
-
The Second Affiliated Hospital of XiAn Jiaotong University
Xi'an, China
-
The Second People's Hospital of Hunan Province（Brain Hospital of Hunan Province）
Changsha, China
-
The Southwest Hospital Of AMU
Chongqing, China
-
The Third Affiliated Hospital of Kunming Medical University Yunnan Cancer Hospital
Kunming, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, China
-
University of Electronic Science and Technology of China, Sichuan Cancer Hospital and Institute & Cancer, The Second People's Hospital of Sichuan Province
Chengdu, China
-
West China Hospital of Sichuan University
Chengdu, China
-
Xiangya Second Hospital of Central South University
Changsha, China
-
Xiangyang Central Hospital
Xiangyang, China
-
Yibin Second People's Hospital
Yibin, China
-
Yuebei People's Hospital
Shaoguan, China
-
Zhejiang Cancer Hospital
Hangzhou, China
-
Zhongshan Hospital of Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.